Scientific Publications

HEADSpAcE publications

  1. Clements K, Thapa A, Cowell A, Conway D, Douglas CM, Paterson C (2024). Impact of the COVID-19 pandemic on stage and incidence of head and neck cancer: a rapid review and meta-analysis. Clin Otolaryngol. 49(4):363–75. https://doi.org/10.1111/coa.14152 PMID:38514776

  2. Popovic M, Fiano V, Moirano G, Chiusa L, Conway DI, Garzino Demo P, et al. (2022). The impact of the COVID-19 pandemic on head and neck cancer diagnosis in the Piedmont region, Italy: interrupted time-series analysis. Front Public Health. 10:809283. https://doi.org/10.3389/fpubh.2022.809283 PMID:35265573

  3. Martínez-Ramírez J, Saldivia-Siracusa C, González-Pérez L-V, Cuadra Zelaya FJM, Gerber-Mora R, Cabrera OFG, et al. (2024). Barriers to early diagnosis and management of oral cancer in Latin America and the Caribbean. Oral Dis. 30(7):4174–84. https://doi.org/10.1111/odi.14903 PMID:38380784

  4. Arboleda LPA, de Carvalho GB, Santos-Silva AR, Fernandes GA, Vartanian JG, Conway DI, et al. (2023). Squamous cell carcinoma of the oral cavity, oropharynx, and larynx: a scoping review of treatment guidelines worldwide. Cancers (Basel). 15(17):4405. https://doi.org/10.3390/cancers15174405 PMID:37686681

  5. Clements K, Cowell A, White G, Flynn W, Conway DI, Douglas CM, et al. (2023). The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: a retrospective cohort study. Clin Otolaryngol. 48(4):587–94. https://doi.org/10.1111/coa.14048 PMID:36929626

  6. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI (2022). Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 233(9):780–6. https://doi.org/10.1038/s41415-022-5166-x PMID:36369568

  7. Creaney G, McMahon AD, Ross AJ, Bhatti LA, Paterson C, Conway DI (2022). Head and neck cancer in the UK: what was the stage before COVID-19? UK cancer registries analysis (2011–2018). Br Dent J. 233(9):787–93. https://doi.org/10.1038/s41415-022-5151-4 PMID:36369569

  8. Ferreiro-Iglesias A, McKay JD, Brenner N, Virani S, Lesseur C, Gaborieau V, et al. (2021). Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 12(1):5945. https://doi.org/10.1038/s41467-021-26151-9 PMID:34642315

  9. Smith CDL, McMahon AD, Lyall DM, Goulart M, Inman GJ, Ross A, et al. (2024). Development and external validation of a head and neck cancer risk prediction model. Head Neck. 46(9):2261–73. https://doi.org/10.1002/hed.27834 PMID:38850089

  10. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al.; HEADSpAcE Consortium (2024). Latin American consensus on the treatment of head and neck cancer. JCO Glob Oncol. 10(10):e2300343. https://doi.org/10.1200/GO.23.00343 PMID:38603656

  11. Creaney G, de Aquino Goulart M, McMahon A, Paterson C, McCaul J, Perdomo S, et al.; HEADSpAcE Consortium (2025). Advanced stage head and neck cancer diagnosis: HEADSpAcE consortium health systems benchmarking survey. Head Neck. 47(7):1977–88. https://doi.org/10.1002/hed.28094 PMID:39994901

  12. Torrens L, Moody S, de Carvalho AC, Kazachkova M, Abedi-Ardekani B, Cheema S, et al. (2025). The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. Nat Genet. 57(4):884–96. https://doi.org/10.1038/s41588-025-02134-0 PMID:40164736

  13. Ebrahimi E, Sangphukieo A, Park HA, Gaborieau V, Ferreiro-Iglesias A, Diergaarde B, et al. (2024). Cross-ancestral GWAS identifies 29 novel variants across head and neck cancer subsites. medRxiv. 2024.11.18.24317473. https://doi.org/10.1101/2024.11.18.24317473

Don’t see your publication? Contact us to add it! (All must acknowledge HEADSpAcE.)